Clinical Trials on Stage 3 Age Related Macular Degeneration (AREDS Classification) in Ireland
Total 9 results
-
Novartis PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationSpain, Italy, Germany, Canada, Ireland
-
BayerCompletedWet Age-related Macular DegenerationCanada, Spain, Sweden, Belgium, Argentina, Italy, Korea, Republic of, United Kingdom, China, Denmark, France, Norway, Colombia, Australia, Ireland, Switzerland, Thailand
-
VisionCare, Inc.RecruitingAge-Related Macular Degeneration | AMDItaly, Ireland, Spain, Germany, United Kingdom
-
NovartisCompletedWet Age-Related Macular DegenerationUnited Kingdom, Switzerland
-
VisionCare, Inc.TerminatedAge Related Macular DegenerationIreland, Spain
-
Jaeb Center for Health ResearchJuvenile Diabetes Research Foundation; National Eye Institute (NEI); National...RecruitingNeovascular Age-related Macular DegenerationUnited States
-
Novartis PharmaceuticalsCompletedNeovascular Age-related Macular DegenerationGermany, Turkey, Austria, Canada, Czechia, United Kingdom, Hungary, Italy, Lithuania, Guatemala, France, Ireland, Argentina, Portugal, Spain, Sweden, Greece, Switzerland, Slovakia, Finland, Netherlands, Colombia, Mexico, Panama
-
Association for Innovation and Biomedical Research...European Vision Institute Clinical Research NetworkActive, not recruitingAtrophy | Age Related Macular Degeneration | Prediction | Intermediate AMDPortugal, France, Germany, Ireland, Italy, Netherlands, Spain, Switzerland, United Kingdom
-
Novartis PharmaceuticalsCompletedDiabetic Macular Edema | Retinal Vein Occlusion | Wet Age Related Macular Degeneration | Wet Age Related Macular Degeneration, Diabetic Macular Edema, Retinal Vein OcclusionSpain, China, Colombia, Korea, Republic of, Belgium, Greece, Japan, Russian Federation, Turkey, United Kingdom, Egypt, Germany, Australia, Canada, France, Austria, Hong Kong, Hungary, Israel, Netherlands, Peru, Singapore, Slovakia, Sl... and more